comparing cardiovascular and kidney outcomes with tirzepatide vs. glp-1 agonists Comparative effectiveness of versus receptor on cardiovascular–kidney–metabolic stage progression: a real-world cohort study GLP1 Receptor Agonists vs SGLT2-I

This GLP-1 medicationbest known by the brand names Ozempic, Wegovy, and Rybelsushas helped many people lose weight and improve metabolic health, including blood sugar control and cardiovascular risk

The receptor belongs to the G-protein coupled 7 transmembrane domain family and has 40% homology to the secretin receptor

& Halpern, B

doi: 10.1002/14651858.CD012990.pub2 66 ChenYZhangYLiLHlscherC

A GLP-1 receptor agonist is a type of medication that stimulates insulin release at high blood glucose levels and suppresses glucagon secretion under low blood glucose conditions

Managing side effects often involves a degree of personalized troubleshooting